| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.6M | +92.6% |
| SG&A Expense | $3K | -8.7% |
| Operating Income | -$1.9M | -80.3% |
| Net Income | -$2.4M | -55.1% |
| EPS (Basic) | -$0.02 | -100.0% |
| EPS (Diluted) | -$0.02 | -100.0% |
| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.1M | -62.0% |
| Current Assets | $1.1M | -62.0% |
| Total Assets | $1.3M | -61.4% |
| Current Liabilities | $2.6M | +23.2% |
| Total Liabilities | $13.1M | +2.8% |
| Stockholders' Equity | -$11.8M | -25.2% |
| Line Item | 2022-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | -82.8% |